Trials / Completed
CompletedNCT00681525
A Multiple-Dose Pharmacokinetic Interaction Study Between ABT-335, Atorvastatin and Ezetimibe
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Abbott · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study is to evaluate the potential PK interaction between ABT-335, atorvastatin 80 mg and ezetimibe 10 mg when administered concurrently.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ABT-335 | One ABT-335 135 mg capsule QD for 10 days |
| DRUG | Atorvastatin | One 80 mg tablet of atorvastatin QD for 10 days |
| DRUG | Ezetimibe | One ezetimibe 10 mg tablet QD for 10 days |
Timeline
- Start date
- 2008-04-01
- Primary completion
- 2008-06-01
- First posted
- 2008-05-21
- Last updated
- 2010-10-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00681525. Inclusion in this directory is not an endorsement.